EN
抗体药类似物
Research Grade Lomtegovimab
All
  • CatalogTD-VK565136
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsBI767551,BI-767551,DZIF-10c,EX14870,EX-14870CAS:2550869-33-3
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Lomtegovimab


Catalog No. TD-VK565136
Species reactivity SARS-CoV-2 (2019-nCoV)
Applications Research Grade Biosimilar
Host species Human
Isotype IgG1, kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, Spike protein S2, Spike protein S2', S, 2, Receptor-Binding Domain, RBD
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P0DTC2-2
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names BI767551,BI-767551,DZIF-10c,EX14870,EX-14870CAS:2550869-33-3
Background Lomtegovimab (BI 767551) is a human anti-SARS-COV-2 spike glycoprotein monoclonal antibody. Lomtegovimab binds and neutralizes SARS-CoV-2. Lomtegovimab shows antiviral efficacy. Lomtegovimab has the potential for the research of COVID-19.
Note For research use only. Not for use in clinical or therapeutic applications.